Krka, d. d. (WSE:KRK)

Poland flag Poland · Delayed Price · Currency is PLN
876.00
+2.00 (0.23%)
Oct 24, 2025, 2:38 PM CET
0.23%
Market Cap26.60B
Revenue (ttm)8.37B
Net Income (ttm)1.62B
Shares Outn/a
EPS (ttm)52.70
PE Ratio16.46
Forward PE16.17
Dividend35.03 (3.89%)
Ex-Dividend DateJul 22, 2025
Volume63
Average Volume126
Open860.00
Previous Close874.00
Day's Range860.00 - 876.00
52-Week Range574.00 - 990.00
Beta0.49
RSI49.03
Earnings DateNov 13, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod... [Read more]

Sector Healthcare
Founded 1954
Employees 11,308
Stock Exchange Warsaw Stock Exchange
Ticker Symbol KRK
Full Company Profile

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.